Join faculty from the SITC 2019 Replay Webinar: Late-Breaking Abstracts Session for an educational webinar on February 20 at 2-2:30 p.m. EST. This webinar is a unique opportunity to engage with Dr. Geoffrey Ku (Memorial Sloan Kettering Cancer Center) during a live question and answer session following a broadcast of their presentations.
The Late-Breaking Abstract Session highlighted cutting-edge science in the immunotherapy field, including Dr. Ku’s presentation, A phase 1 dose escalation study of PRS-343, a HER2/4-1BB bispecific molecule, in patients with HER2-positive malignancies. This SITC 2019 Replay Webinar: Late-Breaking Abstracts offers a chance to directly engage with Dr. Ku regarding his study.
Clinicians, basic and translational researchers, graduate students, post-doctoral fellows, allied health professionals, registered nurses, nurse practitioners and advance practice nurses, pharmacists, and payers are encouraged to attend.Selected Presentation and Faculty
- A phase 1 dose escalation study of PRS-343, a HER2/4-1BB bispecific molecule, in patients with HER2-positive malignancies
- Geoffrey Ku, MD – Memorial Sloan Kettering Cancer Center
to register for this webinar.
Learn more about SITC member benefits.
- SITC members and SITC 2019 attendees: FREE
- Non-members: $25.00